The FDA response was pursuant to a GRAS Notice submitted by BioExx to FDA documenting its conclusion that Isolexx (canola protein isolate) and Vitalexx (hydrolysed canola protein isolate) are GRAS for use in a variety of foods and beverages.
The notice also included a report with such a conclusion from a panel of qualified experts. The notice informed FDA that Isolexx and Vitalexx are GRAS, through scientific procedures, as ingredients in foods such as bakery products, snack foods, beverages, soups, dairy products, dry instant milkshake mixes and protein drinks, instant powdered nutritional beverages, processed meat and poultry products, vegetarian food products/meat analogues and meal replacement and nutritional bars.
While BioExx already has self-affirmed GRAS status for its protein products, the enhanced stature of being GRAS Notified is expected to assist in market recognition and market acceptance, particularly in specialty applications.
The company also notes that its progress continues towards Novel Food Registration with the European Food Safety Authority, and it anticipates completion of the process in the coming months. EU market size and growth, and a strong orientation towards healthy living and sustainability, make this market a key long-term focus for BioExx.
Source: BioExx
© FoodBev Media Ltd 2024